Power3 converts 'Biomarkers for Neurological Disease' provisionals

Four provisional applications claiming biomarkers used in diagnostic procedures for early detection of neurological disease filed by Power3 Medical Products have been converted to utility patent applications.

The filed patents aim to protect the diagnostic testing procedures utilized by the Company in identifying and tracking specific protein biomarkers that could lead to the early detection and diagnosis of neurodegenerative disease. The latest patent applications add to Power3's IP portfolio consisting of numerous patents filed over the last few years for disease biomarkers and diagnostic assays.